Various studies have found increased plasma PCSK9 levels in patients suffering from type 2 diabetes mellitus, metabolic syndrome or obesity (Girona et al., 2016; Levenson et al., 2017; Dijk and Cariou, 2019). Here, PCSK9 is linked to type 2 diabetes mellitus.